首页> 外国专利> VACCINATION OF SEX REVERSED HYBRID TILAPIA (OREOCHROMIS NILOTICUS X O. AUREUS) WITH AN INACTIVATED VIBRIO VULNIFICUS VACCINE

VACCINATION OF SEX REVERSED HYBRID TILAPIA (OREOCHROMIS NILOTICUS X O. AUREUS) WITH AN INACTIVATED VIBRIO VULNIFICUS VACCINE

机译:用灭活弧菌疫苗接种性逆转混合T科(罗非鱼×金黄色葡萄球菌)

摘要

Vibrio vulnificus can cause infections in economically important aquaculture-raised fish and is considered an opportunistic human-pathogen. V. vulnificus was isolated using biochemical and molecular methods. V. vulnificus isolate recovered from diseased tilapia was determined to be biotype 1, 16S rRNA type B, vcg type C, and vvhA type 2. The isolate can cause disease in tilapia held in static salt water (1.5g sea salt/L). Fish vaccinated with formalin-inactivated whole-cell vaccine responded to vaccination as measured by agglutinating antibody titer (vaccinated titers ranged from 32-64 and non- vaccinated titers ranged from 4-8). Vaccinated tilapia exhibited relative survival of 73 and 60% following challenge with the homologous isolate. Vaccinated tilapia exhibited relative survival values of up to 87.5% following challenge with a heterologous isolate. Use of a mineral oil adjuvant enhanced protection. This vaccine provides an effective means of preventing infections caused by biochemically and genetically diverse isolates of V. vulnificus in aquaculture.
机译:创伤弧菌可引起具有重要经济意义的水产养殖养殖鱼类的感染,被认为是机会性人类病原体。使用生化和分子方法分离了V. vulnificus。从患病的罗非鱼中分离出的V. vulnificus分离株被确定为生物型1、16S rRNA B型,vcg C型和vvhA 2型。该分离株可引起罗非鱼在静态盐水(1.5g海盐/ L)中所致的疾病。用凝集抗体滴度(接种的滴度范围为32-64,未接种的滴度范围为4-8)测量,用福尔马林灭活的全细胞疫苗接种的鱼对疫苗接种有反应。用同源分离物攻击后,接种罗非鱼的相对存活率分别为73%和60%。在用异源分离物攻击后,接种罗非鱼的相对存活值高达87.5%。使用矿物油佐剂可增强保护作用。该疫苗为预防由水产养殖中的创伤弧菌的生化和遗传多样性分离株引起的感染提供了有效手段。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号